Acetylon Pharmaceuticals Secures $12,400,000 Series B Financing Round

  • Feed Type
  • Date
    2/22/2011
  • Company Name
    Acetylon Pharmaceuticals
  • Mailing Address
    303 Congress Street 2nd Fl Boston, MA 02210
  • Company Description
    Acetylon Pharmaceuticals is a Boston-based company recently formed to commercialize promising pharmaceutical technology emerging from collaborative research at Harvard University and the Dana-Farber Cancer Institute. Acetylon intends to pursue the clinical development and commercialization of next generation, selective, small-molecule Histone Deacetylase (HDAC) inhibitors with enhanced therapeutic effectiveness and tolerability versus current alternatives.
  • Website
    http://www.acetylon.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,400,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed